These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4374293)

  • 21. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 22. Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine.
    Roberts DC; Zis AP; Fibiger HC
    Brain Res; 1975 Aug; 93(3):441-54. PubMed ID: 1236760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.
    Leibowitz SF
    Brain Res; 1975 Nov; 98(3):529-45. PubMed ID: 1182535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noradrenaline uptake into cerebral cortex: a histochemical study.
    Arbuthnott GW
    J Neurochem; 1969 Dec; 16(12):1599-604. PubMed ID: 4908291
    [No Abstract]   [Full Text] [Related]  

  • 25. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in fluid intake suggesting depressed appetite in rats with central catecholaminergic lesions.
    Sorensen CA; Ellison GD; Masuoka D
    Nat New Biol; 1972 Jun; 237(78):279-81. PubMed ID: 4556589
    [No Abstract]   [Full Text] [Related]  

  • 27. Norepinephrine: reversal of anorexia in rats with lateral hypothalamic damage.
    Berger BD; Wise CD; Stein L
    Science; 1971 Apr; 172(3980):281-4. PubMed ID: 5548711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central and peripheral contributions to the enhancement of amphetamine anorexia by desmethylimipramine (DMI).
    Towell A; Willner P; Booth DA
    Pharmacol Biochem Behav; 1985 Jan; 22(1):57-60. PubMed ID: 3975248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of anorexic doses of dextro-amphetamine on the ventromedial-hypothalamic hyperphagic rat.
    Wishart TB; Walls EK
    Can J Physiol Pharmacol; 1973 May; 51(5):354-9. PubMed ID: 4583556
    [No Abstract]   [Full Text] [Related]  

  • 30. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 31. The action of adrenergic anorexigenic substances on rats recovered from lateral hypothalamic lesions.
    Russek M; Rodríguez-Zendejas AM; Teitelbaum P
    Physiol Behav; 1973 Feb; 10(2):329-33. PubMed ID: 4708499
    [No Abstract]   [Full Text] [Related]  

  • 32. Cholinergic and adrenergic interaction in the hypothalamic control of drinking and eating behavior.
    Singer G; Kelly J
    Physiol Behav; 1972 May; 8(5):885-90. PubMed ID: 5046243
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of hashish smoke sublimate on hypothalamic noradrenaline studies by the fluorescence method.
    Constantinidis J; Miras CJ
    Psychopharmacologia; 1971; 22(1):80-90. PubMed ID: 5119578
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine.
    Häggendal J; Hamberger B
    Acta Physiol Scand; 1967; 70(3):277-80. PubMed ID: 4293470
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioural effects of 6-hydroxydopamine-induced depletion of spinal noradrenaline.
    Roberts DC; McCaughran JA; Fibiger HC
    Can J Physiol Pharmacol; 1979 Nov; 57(11):1223-8. PubMed ID: 519524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic lesions and drug-induced anorexia.
    Blundell JE; Leshem MB
    Postgrad Med J; 1975; 51 Suppl 1():45-54. PubMed ID: 1219679
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of intrahypothalamic 6-hydroxydopamine on motivated responding for food and water in the rat.
    Martin GE; Myers RD
    Pharmacol Biochem Behav; 1974 May; 2(3):393-9. PubMed ID: 4837909
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
    Singer G; Armstrong S; Evans B; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the effects of reserpine and amphetamine on food and water intake.
    Neill DB; Grossman SP
    J Comp Physiol Psychol; 1971 Aug; 76(2):327-36. PubMed ID: 5290737
    [No Abstract]   [Full Text] [Related]  

  • 40. Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine.
    Cooper BR; Howard JL; Grant LD; Smith RD; Breese GR
    Pharmacol Biochem Behav; 1974; 2(5):639-49. PubMed ID: 4610593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.